PI3Kγ controls macrophage PDGF expression to promote PDAC tumor cell invasion. PI3Kγ controls macrophage PDGF expression to promote PDAC tumor cell invasion.

Slides:



Advertisements
Similar presentations
Glioma-derived soluble factor(s) enhance IL-10 signaling.
Advertisements

Yu-fang huang, yi-hui wu, cheng-yang chou*
IL-1β stimulates CXCL5 and CXCL8 gene expression and protein secretion in A549 cells in a time- and dose-dependent manner. IL-1β stimulates CXCL5 and CXCL8.
Akos Heinemann, MD, Gunter J. Sturm, MD, Martina Ofner, BSc, Eva M
Shear stress-stimulated endothelial cells induce smooth muscle cell chemotaxis via platelet-derived growth factor-BB and interleukin-1α  Alan Dardik,
Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets.
Despite a relatively small amount of PI3Kβ being associated with activated PDGFRs, it generates a more substantial proportion of the PIP3 that accumulates.
IL6 secretion is a hallmark of postsenescence.
Combined PLX3397 and PTX treatment inhibits metastasis in a CD8-dependent manner. Combined PLX3397 and PTX treatment inhibits metastasis in a CD8-dependent.
Dienogest inhibits nerve growth factor expression induced by tumor necrosis factor-α or interleukin-1β  Shizuka Mita, M.S., Yutaka Shimizu, Ph.D., Ayumi.
IL-6 is dispensable for the suppressive activity of MDSC on primary CD4+ T-cell activation. IL-6 is dispensable for the suppressive activity of MDSC on.
DQ661 improves survival in colon cancer model and potentiates activity of gemcitabine in KPC pancreatic cancer syngeneic model. DQ661 improves survival.
PDGFRβ is dispensable for EGFRvIII-driven GBM growth but is required for the optimal growth of EGFR-inhibited tumors. PDGFRβ is dispensable for EGFRvIII-driven.
Volume 65, Issue 4, Pages e5 (February 2017)
Volume 13, Issue 12, Pages (December 2015)
Leukocytes in human PDAC
(A) Genotyping of the Lats2 and Cre alleles in the PyMT-derived cell lines (see primers location in Fig S2A). (A) Genotyping of the Lats2 and Cre alleles.
Combination extract inhibits immune responses in vivo.
PI(3,4,5)P3 releases SIN1-PH–mediated inhibition on mTOR-KD, leading to mTORC2 activation. PI(3,4,5)P3 releases SIN1-PH–mediated inhibition on mTOR-KD,
TLR9 deficiency promotes aberrant T cell and myeloid dendritic cell (DC) phenotype in imiquimod-induced autoimmunity. TLR9 deficiency promotes aberrant.
Collagen-dependent phosphorylation of eIF4E in PDAC cells.
Epithelial loss of TβRII results in increased Th17 cell development.
Romain Gallet et al. BTS 2016;1:14-28
Volume 15, Issue 1, Pages (January 2009)
2aG4 directly induces monocytic MDSCs to differentiate into dendritic cells and macrophages by binding to phosphatidylserine on their cell surface. 2aG4.
The selective PI3K inhibitor A66 suppresses PIP3 accumulation, AKT phosphorylation at Thr308, and YAP/TAZ–regulated gene expression in PDAC cells. The.
Volume 25, Issue 1, Pages (January 2017)
VEGF-A concentration is increased in vivo in response to DC101 and in vitro in response to FG VEGF-A concentration is increased in vivo in response.
Pharmacologic inhibitors of PI3Kγ suppress PDAC growth and metastasis.
Regulation by Interleukin-10 and Interleukin-4 of Cyclooxygenase-2 Expression in Human Neutrophils by Hiroaki Niiro, Takeshi Otsuka, Kenji Izuhara, Kunihiro.
Macrophage-produced IL-10 is required but not sufficient for macrophage-stimulated proliferation of ADPKD cells. Macrophage-produced IL-10 is required.
COX-2 deletion in macrophages led to increased renal macrophage infiltration in diabetic mice. COX-2 deletion in macrophages led to increased renal macrophage.
PTX in combination with PLX397 induces antitumor T-cell response.
Reversal of diabetes-induced depletion of bone marrow (BM)–resident LSK cells and impairment of proliferation by ANG-(1-7) treatment. Reversal of diabetes-induced.
DPP-4 enhances M1 polarization and inhibits M2 polarization in macrophages in an ROS-dependent manner. DPP-4 enhances M1 polarization and inhibits M2 polarization.
Upregulation of TRPM2 and production of CXCL2 in cultured macrophages that evoked mechanical allodynia after intraplantar injection. Upregulation of TRPM2.
TRPM2 deficiency impairs carrageenan-induced inflammatory pain.
Reduced tumor growth in CCR5-deficient mice is associated with perturbed killing ability of Treg cells. Reduced tumor growth in CCR5-deficient mice is.
coTCRcys-transduced T cells control tumor growth in vivo.
Cytokine expression in the ileum and colon.
Imatinib mesylate inhibits PDGF-mediated ERK and Akt activation.
TGF-β1 modulates extracellular matrix–mediated MT1-MMP expression.
The effect of IAA on tumor growth in an SK-MEL-28 xenograft model.
IL-13Rα2 promotes cell survival and proliferation.
IDO deficiency delays the development of pulmonary metastases.
IL8 and TNFα are required for neutrophil-induced UMSCC47 increase in invasion. IL8 and TNFα are required for neutrophil-induced UMSCC47 increase in invasion.
Orthotopic PDAC growth is regulated by B cells and FcRγ-positive myeloid cells. Orthotopic PDAC growth is regulated by B cells and FcRγ-positive myeloid.
Neurotensin and insulin induce increases in CTGF, CYR61, and CXCL5 gene expression and stimulate cell proliferation and colony via YAP/TAZ in PDAC cells.
FcRγ signaling regulates BTK activation and mediates PDAC growth.
GM-CSF is required for CA-MSC–induced tumor metastasis.
Prostaglandin E2 attenuates the host antitumor immunity to promote the HFD-induced HCC development. Prostaglandin E2 attenuates the host antitumor immunity.
PDGFAA is a major component of the bioactive fractions generated from Calu-6 conditioned medium. PDGFAA is a major component of the bioactive fractions.
A to C, MetMAb shows strong antitumor activity in the KP4 orthotopic model of pancreatic cancer by ultrasound. A to C, MetMAb shows strong antitumor activity.
MAPK/ERK signaling regulates TLR4 gene expression in response to BRAFV600E. MAPK/ERK signaling regulates TLR4 gene expression in response to BRAFV600E.
IDO deficiency is associated with attenuated induction of IL-6 during 4T1 tumor metastasis. IDO deficiency is associated with attenuated induction of IL-6.
Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Expression.
Anti-CD40 activates TAMs and recruits inflammatory monocytes.
PI3Kγ promotes macrophage PDGF-BB expression to control PDAC fibrosis.
Wnt5A decreases ROR1 expression through proteasomal degradation.
The PI3Kβ inhibitor enhances the antitumor activity of T cell–mediated immunotherapy in mice bearing PTEN loss tumors. The PI3Kβ inhibitor enhances the.
Combination of R848 and anti-CD200R affects activation of tumor-infiltrating myeloid cells. Combination of R848 and anti-CD200R affects activation of tumor-infiltrating.
MYC expression is correlated with dasatinib sensitivity in cancer cell lines and in vivo. MYC expression is correlated with dasatinib sensitivity in cancer.
Tumor-suppressor Lkb1 inactivation promotes neutrophil accumulation via proinflammatory cytokines and chemokines. Tumor-suppressor Lkb1 inactivation promotes.
Expression of chemokine receptors in A-498 cell line.
TNFα-expanded MRD cells acquire the recurrence-competent phenotype.
Fig. 7 Differences in the tumor microenvironment between transplant and transgenic BRAFV600E-driven melanoma models may underlie refractoriness of iBIP2.
In vivo inhibition of IL-17 abrogates tumor-promoting effect of myeloid cells. In vivo inhibition of IL-17 abrogates tumor-promoting effect of myeloid.
Coculture with U937 cells enhances DNMT1 expression in gastric cancer cells. Coculture with U937 cells enhances DNMT1 expression in gastric cancer cells.
Effects of inhibitors of PI3K, MEK1, and GSK-3β on visfatin-induced proliferation in HepG2 cells. Effects of inhibitors of PI3K, MEK1, and GSK-3β on visfatin-induced.
TAMs upregulate DNMT1 in gastric cancer cells through the CCL5/CCR5/STAT3 pathway. TAMs upregulate DNMT1 in gastric cancer cells through the CCL5/CCR5/STAT3.
Presentation transcript:

PI3Kγ controls macrophage PDGF expression to promote PDAC tumor cell invasion. PI3Kγ controls macrophage PDGF expression to promote PDAC tumor cell invasion. A, chemotaxis of LMP PDAC cells toward CM from IL4-stimulated WT or p110γ−/− macrophages (IL4 CM). B, relative mRNA expression of select chemotactic factors in IL4-stimulated p110γ−/− versus WT macrophages as determined by RNA sequencing and expressed as Log2-fold change from WT. C, chemotaxis of LMP PDAC cells toward CM from IL4-stimulated WT macrophages (WT IL4 CM) or RPMI medium in the presence or absence of dilutions of the PDGFR inhibitor imatinib. D, chemotaxis of LMP PDAC cells toward RPMI or CM from IL4-stimulated WT macrophages (WT IL4 CM) in the presence or absence of the PDGF inhibitor Fovista. E, chemotaxis of LMP PDAC cells toward medium (RPMI) or CM from IL4-stimulated WT or p110γ−/− macrophages in the presence or absence of 100 ng/mL CCL2, SCF, PDGF-AA, or PDGF-BB. F, concentration of PDGF-BB in CM from WT and p110γ−/− basal [macrophage colony-stimulating factor (M-CSF)–stimulated] and IL4-stimulated macrophages. G, concentration of PDGF-BB in lysates from p53 2.1.1 orthotopic pancreatic tumors grown in WT and p110γ−/− mice. H, relative mRNA expression of Pdgfb in tumor-derived CD11b+Gr1− macrophages, CD11b+Gr1lo monocytes, CD11b+Gr1hi neutrophils, and CD11b−Gr1− cells (tumor cells). Significance testing was performed by Anova or parametric Student t test. Megan M. Kaneda et al. Cancer Discov 2016;6:870-885 ©2016 by American Association for Cancer Research